Stock Market News2 weeks LLY’s Zepbound Outshines NVO’s Wegovy in Head-to-Head Obesity Study Zacks
LLY’s obesity drug, Zepbound, shows an average weight loss of 20.2%, superior to 13.7% for NVO’s Wegovy in a head-to-head study.
X11 hours Eli Lilly’s Alzheimer’s treatment approved in China Investing.com
X11 hours Eli Lilly Alzheimer’s drug donanemab approved in China Investing.com
X14 hours Eli Lilly (LLY) Stock Moves -0.05%: What You Should Know Zacks
X20 hours NVS vs. LLY: Which Stock Should Value Investors Buy Now? Zacks
X1 day Eli Lilly: A Rare Buying Opportunity Seeking Alpha
X2 days Battle Over Weight-Loss Drugs: Can Eli Lilly, Novo Nordisk Defend Their Turf? Investor's Business Daily
X2 days EMA Panel Endorses Lilly’s Omvoh for Expanded Use in Crohn’s Disease Zacks
X5 days Eli Lilly’s Manjaro gains on Novo Nordisk’s Wegovy in UK Investing.com
X6 days Eli Lilly Reports Positive Data From Late-Stage Breast Cancer Study Zacks
X6 days Eli Lilly Stock Could Have a Huge Growth Catalyst in Early 2025 Yahoo Finance
X7 days Eli Lilly (LLY) Stock Slides as Market Rises: Facts to Know Before You Trade Zacks
X7 days Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly CNBC
X1 week Eli Lilly to test obesity drugs to treat addiction in 2025, CEO says #shorts #weightloss #zepbound YouTube
X1 week Eli Lilly to test obesity drugs for smoking, alcohol abuse – Bloomberg Investing.com
X1 week Oracle, AutoZone and Alaska Air fell premarket; Eli Lilly rose Investing.com
X1 week Lilly Announces New $15B Stock Buyback Plan, Ups Dividend by 15% Zacks
X1 week The Zacks Analyst Blog Highlights Eli Lilly, AbbVie, Gilead Sciences, Air T and Fossil Group Zacks
X1 week Eli Lilly announces $15 billion buyback, dividend hike Investing.com
X1 week Top Stock Reports for Eli Lilly, AbbVie & Gilead Sciences Zacks
X1 week Netflix, Eli Lilly among Monday’s market cap stock movers Investing.com
X1 week Eli Lilly Stock Just Got Even Sweeter. Here’s Why It’s Worth Buying Now Yahoo Finance
X1 week The Zacks Analyst Blog Eli Lilly, Novo Nordisk’s Amgen and Viking Therapeutics Zacks
X2 weeks Eli Lilly to Invest $3B in Wisconsin Plant to Meet Obesity Drug Demand Zacks
X2 weeks Pharma Stock Roundup: LLY’s Zepbound Success, FDA Updates for MRK, JNJ Zacks
X2 weeks How to Play LLY Stock as Zepbound Beats NVO’s Wegovy in Obesity Study Zacks
X2 weeks Eli Lilly Chief Scientific Officer explains Zepbound’s weight loss advantage YouTube
X2 weeks Prescription fills for weight loss drugs Zepbound, Wegovy more than doubled in 2024, GoodRx says CNBC
X2 weeks The Weight-Loss Battle That Could Rattle Eli Lilly’s $100 Billion Market Investor's Business Daily
X2 weeks Eli Lilly Chief Says He Will Fight for the FDA, Challenging RFK Jr.’s Stance The New York Times
X2 weeks Stocks making the biggest moves midday: JetBlue, Eli Lilly, Pure Storage, Salesforce and more CNBC
X2 weeks Eli Lilly says ‘Zepbound superior to Wegovy in head-to-head trial Investing.com
X2 weeks Eli Lilly says Zepbound’s weight-loss results beat those of rival Wegovy MarketWatch
X2 weeks Battle Of The Weight-Loss Behemoths: Eli Lilly Whomps Novo Nordisk Investor's Business Daily
X2 weeks Eli Lilly stock higher following surprise weight loss treatment data TheStreet
X2 weeks Eli Lilly Just Got a Bundle of Good News: Time to Buy? Yahoo Finance
X2 weeks Eli Lilly’s Zepbound causes greater weight loss than Novo Nordisk’s Wegovy in head-to-head trial CNBC
X2 weeks Lightning Round: I prefer Eli Lilly over Regeneron YouTube
X3 weeks Eli Lilly and Novo Nordisk’s Obesity Moat Just Got Stronger The Wall Street Journal
X3 weeks Why Is Lilly (LLY) Down 5% Since Last Earnings Report? Zacks
X3 weeks Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It Zacks
X3 weeks Eli Lilly: An Early Christmas Present Has Just Arrived (Rating Upgrade) Seeking Alpha
X3 weeks Calls of the Day: Martin Marietta, Datadog, Bristol-Myers, Eli Lilly and Disney YouTube
X3 weeks LLY, NVO Stock Up as Biden Proposes Medicare Cover for Obesity Drugs Zacks
X3 weeks Eli Lilly, Amazon lead market cap stock movers on Tuesday Investing.com
X3 weeks Amgen Dives 5% Despite ‘Truly Remarkable’ Results For Obesity Treatment Investor's Business Daily
X3 weeks These Stocks Are Moving the Most Today: GM, Ford, Amgen, Eli Lilly, Super Micro, Best Buy, Analog Devices, Kohl’s, Semtech, and More Yahoo Finance
X4 weeks Eli Lilly: Steep Pullback, Still Compelling Here Seeking Alpha
X4 weeks Billionaire Israel Englander Increased His Stake In Eli Lilly During the Third Quarter: Should You? Yahoo Finance
X4 weeks RFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk Be Worried? Investor's Business Daily
X4 weeks Eli Lilly Stock: Unexpected Developments (Rating Downgrade) Seeking Alpha
XThe Stock Market News
TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.